{
  "pmid": "35858159",
  "uid": "35858159",
  "title": "Response by Lam and Gerstein to Letter Regarding Article, \"Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial\".",
  "abstract": "",
  "authors": [
    {
      "last_name": "Lam",
      "fore_name": "Carolyn S P",
      "initials": "CSP",
      "name": "Carolyn S P Lam",
      "affiliations": [
        "National Heart Centre Singapore & Duke-National University of Singapore (C.S.P.L.)."
      ],
      "orcid": "0000-0003-1903-0018"
    },
    {
      "last_name": "Gerstein",
      "fore_name": "Hertzel C",
      "initials": "HC",
      "name": "Hertzel C Gerstein",
      "affiliations": [
        "Population Health Research Institute, Hamilton Health Sciences and McMaster University, Canada (H.C.G.)."
      ],
      "orcid": "0000-0001-8072-2836"
    },
    {
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Circulation",
    "iso_abbreviation": "Circulation",
    "issn": "1524-4539",
    "issn_type": "Electronic",
    "volume": "146",
    "issue": "2",
    "pub_year": "2022",
    "pub_month": "Jul",
    "pub_day": "12"
  },
  "start_page": "e7",
  "pages": "e7",
  "language": "eng",
  "publication_types": [
    "Letter",
    "Comment"
  ],
  "keywords": [],
  "article_ids": {
    "pubmed": "35858159",
    "doi": "10.1161/CIRCULATIONAHA.122.060526"
  },
  "doi": "10.1161/CIRCULATIONAHA.122.060526",
  "dates": {
    "completed": "2022-07-22",
    "revised": "2024-04-03"
  },
  "chemicals": [],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:22:49.738519",
    "pmid": "35858159"
  }
}